Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
NB-003 by NewBay Medical Technology for Metastatic Melanoma: Likelihood of Approval
NB-003 is under clinical development by NewBay Medical Technology and currently in Phase I for Metastatic Melanoma. According to GlobalData,...
Data Insights
NB-003 by NewBay Medical Technology for Gastrointestinal Stromal Tumor (GIST): Likelihood of Approval
NB-003 is under clinical development by NewBay Medical Technology and currently in Phase I for Gastrointestinal Stromal Tumor (GIST). According...